BioSpace News Archive

Press Releases

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

March 27, 2026
·
21 min read
Press Releases

BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI® Approval in Outpatient Setting

March 27, 2026
·
17 min read
Press Releases

Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)

March 27, 2026
·
12 min read
Press Releases

Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of STAR-001

March 27, 2026
·
12 min read
Press Releases

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates

March 27, 2026
·
8 min read
Press Releases

Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026

March 27, 2026
·
7 min read
Press Releases

Satellos Reports 2025 Financial Results and Highlights Recent Company Progress

March 27, 2026
·
11 min read
Press Releases

Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

March 27, 2026
·
8 min read
Press Releases

Arletta Pharma Solutions Announces Positive Results from Phase II Clitoral Doppler Duplex Ultrasound Study of Lybrido™ Combination Targeting Female Sexual Dysfunction

March 27, 2026
·
8 min read
Press Releases

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference

March 27, 2026
·
4 min read